Pmu30 - Budget and Health Impact of Immuno-Oncology Treatments in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1866
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immuno‐Oncology Forum

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

The Role of Radiation Oncology in Immuno‐Oncology

Oncologist
Cancer ResearchMedicineOncology
2019English

Immuno-Oncology and Immunotherapy

2012English

Mevalonate Metabolism in Immuno-Oncology

Frontiers in Immunology
AllergyImmunology
2017English

Immuno‐oncology for Surgeons

British Journal of Surgery
Surgery
2019English

Budget Impact Analysis of Apixaban to Treat and Prevent Venous Thromboembolism in Italy

Farmeconomia. Health economics and therapeutic pathways
2016English

Pcn345 - Health State Utilities in Metastatic Nsclc: A Study of Multiple Immuno-Oncology Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prm148 - Health Technology Assessment Agency Appraisal of Immuno-Oncology Cure Fraction Survival Modelling

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php181 - Health Technology Assessment of Oncology Therapies in Spain and Italy: Key Metrics and Considerations

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy